{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":335863,"items":[{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:19:40Z","timestamp":1770826780049,"version":"3.50.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m4089_10101_01","type":"standard","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:41:43Z","timestamp":1770824503000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan Hydrobromide"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:41:51Z","timestamp":1770824511000},"score":22.992367,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M4089_10101_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m4089_10101_01"},{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:19:48Z","timestamp":1770826788894,"version":"3.50.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m4090_10201_01","type":"standard","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:41:43Z","timestamp":1770824503000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:42:05Z","timestamp":1770824525000},"score":22.645187,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M4090_10201_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m4090_10201_01"},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:52:32Z","timestamp":1791881552528,"version":"4.3.4"},"description":"Drug","reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.18578\/bnf.385016143","type":"component","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T08:47:16Z","timestamp":1447404436000},"source":"Crossref","is-referenced-by-count":0,"title":["eletriptan"],"prefix":"10.18578","member":"162","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:27:16Z","timestamp":1791880036000},"score":22.189716,"resource":{"primary":{"URL":"https:\/\/www.medicinescomplete.com\/#\/content\/bnf\/_385016143"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18578\/bnf.385016143","relation":{"is-component-of":[{"id-type":"doi","id":"10.18578\/BNF.147942626","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T04:48:09Z","timestamp":1664254089694},"reference-count":0,"publisher":"Bloomsbury Academic","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011]]},"DOI":"10.5040\/9781350363595.art-615","type":"book-chapter","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:22:06Z","timestamp":1664202126000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan."],"prefix":"10.5040","member":"2984","container-title":["Drugs Handbook 2012\u20132013"],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:34:06Z","timestamp":1664202846000},"score":20.344135,"resource":{"primary":{"URL":"http:\/\/www.bloomsburycollections.com\/book\/drugs-handbook-20122013\/"}},"issued":{"date-parts":[[2011]]},"references-count":0,"URL":"https:\/\/doi.org\/10.5040\/9781350363595.art-615","published":{"date-parts":[[2011]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:17:44Z","timestamp":1648599464900},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1049","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.2165\/00128415-200510490-00028","type":"journal-article","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T05:22:46Z","timestamp":1138252966000},"page":"8","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan\/naratriptan\/sumatriptan"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Reactions Weekly"],"language":"en","deposited":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T11:23:58Z","timestamp":1362223438000},"score":19.713188,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128415-200510490-00028"}},"subtitle":["Allergy (first report with eletriptan and naratriptan): 2 case reports"],"issued":{"date-parts":[[2005,4]]},"references-count":0,"journal-issue":{"issue":"1049"},"URL":"https:\/\/doi.org\/10.2165\/00128415-200510490-00028","ISSN":["0114-9954"],"issn-type":[{"value":"0114-9954","type":"print"}],"published":{"date-parts":[[2005,4]]}},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:14:56Z","timestamp":1726049696374},"reference-count":1,"publisher":"Qeios","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.32388\/6nsws8","type":"reference-entry","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T13:38:46Z","timestamp":1581082726000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan Hydrobromide"],"prefix":"10.32388","author":[{"name":"National Cancer Institute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17262","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute. Eletriptan Hydrobromide. NCI Thesaurus. Code C47508."}],"container-title":["Definitions"],"language":"en","deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T13:38:46Z","timestamp":1581082726000},"score":19.653608,"resource":{"primary":{"URL":"https:\/\/www.qeios.com\/read\/definition\/59746"}},"issued":{"date-parts":[[2020,2,7]]},"references-count":1,"URL":"https:\/\/doi.org\/10.32388\/6nsws8","published":{"date-parts":[[2020,2,7]]}},{"indexed":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T22:12:38Z","timestamp":1655071958142},"edition-number":"1","reference-count":5,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2012,9,6]]},"DOI":"10.1017\/cbo9781139194464.037","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:04:39Z","timestamp":1349535879000},"page":"158-160","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan"],"prefix":"10.1017","member":"56","reference":[{"key":"9781139194464.CBO9781139194464A043_CBO9781139194464bib226","doi-asserted-by":"crossref","unstructured":"Dodick D Lipton RB Martin V Triptan Cardiovascular Safety Expert Panel. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine Headache 2004 44 414","DOI":"10.1111\/j.1526-4610.2004.04078.x"},{"key":"9781139194464.CBO9781139194464A043_CBO9781139194464bib228","doi-asserted-by":"crossref","unstructured":"Gladstone JP Gawel M Newer formulations of the triptans: advances in migraine management Drugs 2003 63 2285","DOI":"10.2165\/00003495-200363210-00002"},{"key":"9781139194464.CBO9781139194464A043_CBO9781139194464bib230","doi-asserted-by":"crossref","unstructured":"Goldstein JA Massey KD Kirby S Effect of high-dose intravenous eletriptan on coronary artery diameter Cephalalgia 2004 24 515","DOI":"10.1111\/j.1468-2982.2003.00713.x"},{"key":"9781139194464.CBO9781139194464A043_CBO9781139194464bib229","doi-asserted-by":"crossref","unstructured":"Goadsby PJ Zanchin G Geraud G Early vs. non-early intervention in acute migraine \u2013 Act when Mild (AwM)\u2019: a double-blind, placebo-controlled trial of almotriptan Cephalalgia 2008 28 383","DOI":"10.1111\/j.1468-2982.2008.01546.x"},{"key":"9781139194464.CBO9781139194464A043_CBO9781139194464bib227","doi-asserted-by":"crossref","unstructured":"Ferrari MD Roon KI Lipton RB Goadsby PJ Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials Lancet 2001 358 1668","DOI":"10.1016\/S0140-6736(01)06711-3"}],"container-title":["Essential Pain Pharmacology"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/D244D52E296F80991B4237B310F28537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T21:42:06Z","timestamp":1655070126000},"score":18.66295,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9781139194464A043\/type\/book_part"}},"issued":{"date-parts":[[2012,9,6]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1017\/cbo9781139194464.037","published":{"date-parts":[[2012,9,6]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:49:39Z","timestamp":1648597779635},"reference-count":9,"publisher":"Infomed-Verlags AG","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["pk"],"published-print":{"date-parts":[[2002,5,29]]},"abstract":"<jats:p>N\/A<\/jats:p>","DOI":"10.37667\/pk.2002.46","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:16:23Z","timestamp":1584472583000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan"],"prefix":"10.37667","volume":"24","author":[{"given":"Regina","family":"Suter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24093","reference":[{"key":"ref1","unstructured":"Spanaus K. pharma-kritik 1998; 20: 45-8"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Jhee SS et al. Clin Pharmacokinet 2001; 40: 189-205","DOI":"10.2165\/00003088-200140030-00004"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Tfelt-Hansen P et al. Drugs 2000; 60: 1259-87","DOI":"10.2165\/00003495-200060060-00003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Tepper SJ. Med Clin North Am 2001; 85: 959-70","DOI":"10.1016\/S0025-7125(05)70353-9"},{"key":"ref5","unstructured":"Smith LA et al. Cochrane Database Syst Rev 2001; 3: CD003224"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Goadsby PJ et al. Neurology 2000; 54: 156-63","DOI":"10.1212\/WNL.54.1.156"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ferrari MD et al. Lancet 2001; 358: 1668-75","DOI":"10.1016\/S0140-6736(01)06711-3"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Diener HC et al. Eur Neurol 2002; 47: 99-107","DOI":"10.1159\/000047960"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Katsarava Z et al. Drug Saf 2001; 24: 921-7","DOI":"10.2165\/00002018-200124120-00005"}],"container-title":["pharma-kritik"],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:16:26Z","timestamp":1584472586000},"score":18.312843,"resource":{"primary":{"URL":"https:\/\/www.infomed.ch\/pk_template.php?pkid=46"}},"issued":{"date-parts":[[2002,5,29]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,5,29]]}},"URL":"https:\/\/doi.org\/10.37667\/pk.2002.46","ISSN":["1010-5409"],"issn-type":[{"value":"1010-5409","type":"print"}],"published":{"date-parts":[[2002,5,29]]}},{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T23:13:57Z","timestamp":1654989237410},"edition-number":"2","reference-count":0,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"unspecified","delay-in-days":1818,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"unspecified","delay-in-days":1818,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015,10,15]]},"DOI":"10.1017\/9781316161753.055","type":"other","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:08:19Z","timestamp":1601942899000},"page":"201-204","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan"],"prefix":"10.1017","member":"56","container-title":["Essential Neuropharmacology"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/249D04BB62DB6D5BB58F66611E48D120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T22:32:05Z","timestamp":1654986725000},"score":18.177687,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/9781316161753%23c54\/type\/book_part"}},"issued":{"date-parts":[[2015,10,15]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1017\/9781316161753.055","published":{"date-parts":[[2015,10,15]]}},{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T10:28:00Z","timestamp":1725532080725},"edition-number":"1","reference-count":0,"publisher":"Wiley","isbn-type":[{"type":"electronic","value":"9780471922247"}],"license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1002\/0471922242.pdh00027","type":"other","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T11:51:54Z","timestamp":1257421914000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan (\n            <i>generic<\/i>\n            ) \u223c Relpax (\n            <i>brand<\/i>\n            )"],"prefix":"10.1002","member":"311","published-online":{"date-parts":[[2005,10]]},"container-title":["Psychotropic Drug Handout"],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/0471922242.pdh00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T10:30:52Z","timestamp":1693132252000},"score":17.936657,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/0471922242.pdh00027"}},"issued":{"date-parts":[[2005,10]]},"ISBN":["9780471922247"],"references-count":0,"alternative-id":["10.1002\/0471922242.pdh00027","10.1002\/0471922242"],"URL":"https:\/\/doi.org\/10.1002\/0471922242.pdh00027","archive":["Portico"],"published":{"date-parts":[[2005,10]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:49:05Z","timestamp":1648882145557},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1516","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inpharma Weekly"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.2165\/00128413-200515160-00008","type":"journal-article","created":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T05:24:03Z","timestamp":1137993843000},"page":"4","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan cost-effective migraine treatment"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Inpharma Weekly"],"language":"en","deposited":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T01:51:06Z","timestamp":1362102666000},"score":17.451538,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128413-200515160-00008"}},"subtitle":[""],"issued":{"date-parts":[[2005,12]]},"references-count":0,"journal-issue":{"issue":"1516"},"URL":"https:\/\/doi.org\/10.2165\/00128413-200515160-00008","ISSN":["1173-8324"],"issn-type":[{"value":"1173-8324","type":"print"}],"published":{"date-parts":[[2005,12]]}},{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:40:21Z","timestamp":1713980421888},"reference-count":0,"publisher":"Pan Health Care Research Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Res. J. Pharm."],"DOI":"10.7897\/2230-8407.04640","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T21:36:34Z","timestamp":1372973794000},"page":"179-182","source":"Crossref","is-referenced-by-count":3,"title":["DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF ELETRIPTAN IN ELETRIPTAN HYDROBROMIDE ORALLY DISINTEGRATING TABLETS"],"prefix":"10.56802","volume":"4","author":[{"given":"Pradeep Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subas Chandra","family":"Dinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36253","published-online":{"date-parts":[[2013,7,5]]},"container-title":["INTERNATIONAL RESEARCH JOURNAL OF PHARMACY"],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:16:26Z","timestamp":1713978986000},"score":17.370457,"resource":{"primary":{"URL":"http:\/\/www.irjponline.com\/admin\/php\/uploads\/1862_pdf.pdf"}},"issued":{"date-parts":[[2013,7,5]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,7,5]]}},"URL":"https:\/\/doi.org\/10.7897\/2230-8407.04640","ISSN":["2230-8407"],"issn-type":[{"value":"2230-8407","type":"electronic"}],"published":{"date-parts":[[2013,7,5]]}},{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:58:39Z","timestamp":1725483519487},"reference-count":20,"publisher":"Hindawi Limited","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2945,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1111\/j.1742-1241.2007.01513.x","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T15:57:19Z","timestamp":1186675039000},"page":"1677-1685","source":"Crossref","is-referenced-by-count":9,"title":["Patient satisfaction with eletriptan in the acute treatment of migraine in primary care"],"prefix":"10.1155","volume":"61","author":[{"given":"R. B.","family":"Nett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Almas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"Sikes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2007,8,9]]},"reference":[{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB2|cit2","volume-title":"Drug Class Review on Triptans","author":"Helfand","year":"2006"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(02)00024-6","article-title":"Pharmacological treatments for acute migraine: quantitative systematic review","volume":"97","author":"Oldman","year":"2002","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0528.1998.tb01940.x","article-title":"Satisfaction as a determinant of compliance","volume":"26","author":"Albrecht","year":"1998","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.1999.00006.x","article-title":"Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?","volume":"39","author":"Lipton","year":"1999","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/WNL.60.3.441","article-title":"Patterns of health care utilization for migraine in England and in the United States","volume":"60","author":"Lipton","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. D","key":"10.1111\/j.1742-1241.2007.01513.x-BIB7|cit7","first-page":"25","article-title":"Migraine medication attributes are important for patient compliance","volume":"39","author":"Massiou","year":"2003","journal-title":"Drugs Today (Barc)"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.clinthera.2004.09.011","article-title":"Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)","volume":"26","author":"Cutrer","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-005-0769-0","article-title":"The use of multiattribute decision models in evaluating triptan treatment options in migraine","volume":"252","author":"Ferrari","year":"2005","journal-title":"J Neurol"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1185\/030079905X36387","article-title":"How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians","volume":"21","author":"Lipton","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB11|cit11","first-page":"1","article-title":"Classification and diagnosis criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","article-title":"A self-administered screener for migraine in primary care: the ID Migraine validation study","volume":"61","author":"Lipton","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1468-2982.2000.00082.x","article-title":"Determinants of patient satisfaction with migraine therapy","volume":"20","author":"Davies","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1526-4610.1995.hed3506330.x","article-title":"Validation of a new quality of life questionnaire for acute migraine headache","volume":"35","author":"Santanello","year":"1995","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1526-4610.1995.hed3506320.x","article-title":"Development of a brief 24-hour migraine-specific quality of life questionnaire","volume":"35","author":"Hartmaier","year":"1995","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1524-4733.2005.00047.x","article-title":"Functional Assessment in Migraine (FAIM) questionnaire: development of an instrument based upon the WHO's International Classification of Functioning, Disability, and Health","volume":"8","author":"Pathak","year":"2005","journal-title":"Value Health"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB17|cit17","volume-title":"Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance","author":"International Conference on Harmonization","year":"1996"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","article-title":"What do patients with migraine want from acute migraine treatment?","volume":"42","author":"Lipton","year":"2002","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1468-2982.2003.00554.x","article-title":"Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan","volume":"23","author":"F\u00e4rkkil\u00e4","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01513.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1526-4610.2006.00505.x","article-title":"Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan","volume":"46","author":"Goldstein","year":"2006","journal-title":"Headache"}],"container-title":["International Journal of Clinical Practice"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2007.01513.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2007.01513.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:08Z","timestamp":1643349908000},"score":17.284235,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2007.01513.x"}},"subtitle":["Patient satisfaction with eletriptan for migraine"],"issued":{"date-parts":[[2007,8,9]]},"references-count":20,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01513.x","ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"published":{"date-parts":[[2007,8,9]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:43:27Z","timestamp":1648881807508},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1401","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inpharma Weekly"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.2165\/00128413-200314010-00008","type":"journal-article","created":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T00:19:49Z","timestamp":1137975589000},"page":"4","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan economically superior to sumatriptan in migraine"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Inpharma Weekly"],"language":"en","deposited":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T23:51:04Z","timestamp":1362095464000},"score":17.27243,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128413-200314010-00008"}},"subtitle":[""],"issued":{"date-parts":[[2003,8]]},"references-count":0,"journal-issue":{"issue":"1401"},"URL":"https:\/\/doi.org\/10.2165\/00128413-200314010-00008","ISSN":["1173-8324"],"issn-type":[{"value":"1173-8324","type":"print"}],"published":{"date-parts":[[2003,8]]}},{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T09:35:52Z","timestamp":1715765752875},"reference-count":0,"publisher":"Oxford University PressNew York, NY","isbn-type":[{"value":"9780192632142","type":"print"},{"value":"9781383002010","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Eletriptan (Relpax?) is a potent and selective 5-HT1B\/1D agonist that has been developed as an oral therapy for the acute relief of migraine symptoms. Specifcally, eletriptan was designed with the potential for high clinical efficacy and a rapid onset of action and the drug exhibits improved pharmacological and pharmacokinetic properties compared with oral sumatriptan. This review will summarize the current data relating to the pharmacological and pharmacokinetic profile of eletriptan and provide an overview of the current clinical experience with eletriptan.<\/jats:p>","DOI":"10.1093\/oso\/9780192632142.003.0034","type":"book-chapter","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T16:17:01Z","timestamp":1699114621000},"page":"236-246","source":"Crossref","is-referenced-by-count":0,"title":["Experience with eletriptan"],"prefix":"10.1093","author":[{"given":"Neville","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["The Triptans: Novel Drugs for Migraine"],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/book\/chapter-pdf\/52494239\/isbn-9780192632142-book-part-34.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T16:17:46Z","timestamp":1699114666000},"score":17.18098,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/book\/54113\/chapter\/422393075"}},"issued":{"date-parts":[[2001,11,1]]},"ISBN":["9780192632142","9781383002010"],"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/oso\/9780192632142.003.0034","published":{"date-parts":[[2001,11,1]]}},{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:06:40Z","timestamp":1775228800281,"version":"3.50.1"},"reference-count":0,"publisher":"Therapeutic Guidelines Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Prescr"],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.18773\/austprescr.2010.091","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:50:51Z","timestamp":1453683051000},"page":"193-198","source":"Crossref","is-referenced-by-count":0,"title":["New drugs: Eletriptan hydrochloride"],"prefix":"10.18773","volume":"33","member":"39051","container-title":["Australian Prescriber"],"link":[{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/eletriptan-hydrochloride.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:19:37Z","timestamp":1775225977000},"score":17.072092,"resource":{"primary":{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/eletriptan-hydrochloride.html"}},"issued":{"date-parts":[[2010,12,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.18773\/austprescr.2010.091","ISSN":["0312-8008","1839-3942"],"issn-type":[{"value":"0312-8008","type":"print"},{"value":"1839-3942","type":"electronic"}],"published":{"date-parts":[[2010,12,1]]}},{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:50Z","timestamp":1740144170844,"version":"3.37.3"},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s40278-013-0573-z","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T08:10:28Z","timestamp":1357978228000},"page":"25-25","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan"],"prefix":"10.1007","volume":"1434","member":"297","published-online":{"date-parts":[[2013,1,12]]},"reference":[{"issue":"12","key":"573_CR1","first-page":"907","volume":"50","author":"H Yilmaz","year":"2012","unstructured":"Yilmaz H, et al. A case of hyperprolactinemia, probably induced by eletriptan. International Journal of Clinical Pharmacology and Therapeutics 50: 907-908, No. 12, Dec 2012. Available from: URL: http:\/\/dx.doi.org\/10.5414\/CP201744 - Turkey","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-013-0573-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-013-0573-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-013-0573-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:59:26Z","timestamp":1559491166000},"score":17.008526,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-013-0573-z"}},"subtitle":["Hyperprolactinaemia: case report"],"issued":{"date-parts":[[2013,1]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1007\/s40278-013-0573-z","ISSN":["0114-9954","1179-2051"],"issn-type":[{"type":"print","value":"0114-9954"},{"type":"electronic","value":"1179-2051"}],"published":{"date-parts":[[2013,1]]}},{"indexed":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T14:41:39Z","timestamp":1732286499575,"version":"3.28.0"},"publisher-location":"Stuttgart","edition-number":"6","reference-count":0,"publisher":"Georg Thieme Verlag","isbn-type":[{"type":"print","value":"9783131308566"},{"type":"electronic","value":"9783131932068"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2013]]},"DOI":"10.1055\/b-0034-82393","type":"book-chapter","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T14:32:42Z","timestamp":1403015562000},"source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan"],"prefix":"10.1055","member":"194","container-title":["Checkliste Arzneimittel A\u2013Z"],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ebooks\/pdf\/10.1055\/b-0034-82393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T14:02:03Z","timestamp":1732284123000},"score":16.850216,"resource":{"primary":{"URL":"https:\/\/eref.thieme.de\/10.1055\/b-0034-82393"}},"editor":[{"given":"Detlev","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Frank","family":"Richling","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"issued":{"date-parts":[[2013]]},"ISBN":["9783131308566","9783131932068"],"references-count":0,"URL":"https:\/\/doi.org\/10.1055\/b-0034-82393","published":{"date-parts":[[2013]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:38:29Z","timestamp":1648798709167},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1418","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inpharma Weekly"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.2165\/00128413-200314180-00040","type":"journal-article","created":{"date-parts":[[2006,1,22]],"date-time":"2006-01-22T19:25:41Z","timestamp":1137957941000},"page":"18","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan superior to zolmitriptan in acute migraine"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Inpharma Weekly"],"language":"en","deposited":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T19:01:22Z","timestamp":1362078082000},"score":16.821133,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128413-200314180-00040"}},"subtitle":[""],"issued":{"date-parts":[[2003,12]]},"references-count":0,"journal-issue":{"issue":"1418"},"URL":"https:\/\/doi.org\/10.2165\/00128413-200314180-00040","ISSN":["1173-8324"],"issn-type":[{"value":"1173-8324","type":"print"}],"published":{"date-parts":[[2003,12]]}},{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:09:10Z","timestamp":1749010150977,"version":"3.41.0"},"reference-count":0,"publisher":"Genesis Global Publication","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Res. Publ. Rev."],"DOI":"10.55248\/gengpi.6.0525.1918","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:09:52Z","timestamp":1748934592000},"page":"13560-13565","source":"Crossref","is-referenced-by-count":0,"title":["Formulation and Evaluation of Fast Disintegrating Tablet of Eletriptan Hydrobromide"],"prefix":"10.55248","volume":"6","author":[{"given":"Vishal B","family":"Ambekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mr.Babasaheb L","family":"Chopade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr.Megha T","family":"Salve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34006","published-online":{"date-parts":[[2025,5]]},"container-title":["International Journal of Research Publication and Reviews"],"original-title":["Formulation and Evaluation of Fast Disintegrating Tablet of Eletriptan Hydrobromide"],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:09:59Z","timestamp":1748934599000},"score":16.744713,"resource":{"primary":{"URL":"https:\/\/ijrpr.com\/uploads\/V6ISSUE5\/IJRPR46575.pdf"}},"issued":{"date-parts":[[2025,5]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"URL":"https:\/\/doi.org\/10.55248\/gengpi.6.0525.1918","ISSN":["2582-7421"],"issn-type":[{"value":"2582-7421","type":"electronic"}],"published":{"date-parts":[[2025,5]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}